The human homologue of the vesicular acetylcholine transporter (hVAChT) and the neuronal isoform of the vesicular monoamine transporter (hVMAT2) are differentially targeted to two populations of regulated secretory organelles when expressed in PC12 cells. Western blot analysis of subcellular fractions from sucrose equilibrium density gradients and glycerol velocity gradients of homogenates from stably transfected cells revealed hVAChT immunoreactivity in fractions that contain synaptophysin, a marker of synaptic vesicles, while hVMAT2 immunoreactivity was confined to heavy fractions containing chromogranin B, a marker of large dense core vesicles. In cells treated with nerve growth factor, hVAChT immunoreactivity alone co-localized with synaptophysin and was abundantly expressed on synaptic vesicle clusters. Chimeras between hVMAT2 and hVAChT were utilized to identify the domain of hVAChT required for its expression on synaptic vesicles and which would shift the expression of hVMAT2 from large dense core vesicles to synaptic vesicles. Biochemical, immunocytochemical, and electron microscopic analyses revealed that a chimera in which the cytoplasmic tail of hVMAT2 was replaced with hVAChT sequences was now preferentially targeted to synaptic vesicles. In addition, hVAChT expression on synaptic vesicles was nearly abolished when the hVMAT2 cytoplasmic tail was present. Thus, structural information resides within the terminal cytoplasmic domain of VAChT, which specifically targets it to synaptic vesicles.The organelles used for regulated biogenic amine and acetylcholine (ACh) 1 secretion in neurons and endocrine cells are the large and small dense core vesicles (DCV) and small synaptic vesicles, respectively. The biogenesis and fate of these organelles and targeting of various proteins to them differ in several ways (1-6). LDCVs (approximately 200 nm) are the product of the trans-Golgi network as they contain soluble glycoproteins, such as the chromogranins, and various neuropeptides. Following maturation and subsequent exocytosis at the plasma membrane, components of the LDCV membrane must recycle to the Golgi complex to replenish their soluble neurohormone content and re-enter the regulated secretory pathway. In contrast, synaptic vesicle proteins, such as synaptophysin (p38), appear to travel to the plasma membrane via the constitutive secretory pathway and are then endocytosed and sorted in endosomes, from which synaptic vesicles (40 nm) bud. Exocytosis/endocytosis and recycling of cholinergic synaptic vesicles takes place at the presynaptic nerve terminal, while neuropeptide-and monoamine-containing LDCVs, located throughout the cell, may release nonsynaptically (7-10).Cloning and characterization of the family of vesicular transporters for biogenic amines and ACh has provided new tools for the study of the biogenesis of these regulated secretory organelles (11, 12). The examination of the subcellular localization of these proteins indicates that they are associated with distinct vesicle populations in neurons...